药品的定价与价值.pptxVIP

 ;;My interests and prejudices (?);;Changing research and development challenges;The VBP offer as developed in the UK by York and NICE;Pharmaceutical spending in total health spendingSource: Pharmaceutical pricing in a global market, OECD, 2008 ;Pharmaceutical retail price componentsSource: Pharmaceutical pricing in a global market, OECD, 2008;Some key dates in UK and EU drug pricing;What are we trying to do with pricing policies?;Approaches to (drug) price regulation;In the UK Alzheimer’s disease care provides a good illustration of a field where the actual cost of a disputed med